
Europlasma (ALEUP) | Financial Analysis & Statements
Europlasma | Small-cap | Industrials
Europlasma | Small-cap | Industrials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
62.9M
Total Liabilities
74.0M
Shareholders Equity
-11.1M
Cash Flow Metrics
Revenue & Profitability Trend
Europlasma Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 42.5M | 15.4M | 14.5M | 9.8M | 3.8M |
Cost of Goods Sold | 19.8M | 11.7M | 8.8M | 4.7M | 2.2M |
Gross Profit | 22.6M | 3.7M | 5.7M | 5.1M | 1.6M |
Gross Margin % | 53.3% | 24.3% | 39.3% | 51.7% | 42.6% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | 3.6M | 1.9M |
Other Operating Expenses | 11.5M | 4.4M | 3.2M | 3.8M | 2.5M |
Total Operating Expenses | 11.5M | 4.4M | 3.2M | 7.4M | 4.3M |
Operating Income | -26.1M | -20.0M | -16.2M | -11.7M | -12.0M |
Operating Margin % | -61.5% | -129.5% | -111.3% | -119.1% | -315.5% |
Non-Operating Items | |||||
Interest Income | 14.0K | 40.0K | 8.0K | 2.0K | 13.0K |
Interest Expense | 3.1M | 3.6M | 5.7M | 6.3M | 14.9M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -18.7M | -15.1M | -16.0M | -12.5M | -10.6M |
Income Tax | -2.8M | -355.0K | -241.0K | -299.0K | 0 |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -15.9M | -14.7M | -15.8M | -12.7M | -10.6M |
Net Margin % | -37.5% | -95.7% | -108.5% | -129.3% | -280.3% |
Key Metrics | |||||
EBITDA | -6.5M | -5.1M | -9.9M | -8.9M | -10.5M |
EPS (Basic) | €-0.02 | €-0.21 | €-15.00 | €-0.43 | €-9,463.60 |
EPS (Diluted) | €-0.02 | €-0.21 | €-15.00 | €-0.43 | €-9,463.60 |
Basic Shares Outstanding | 1013922344 | 70364060 | 1209909 | 29982557 | 1044 |
Diluted Shares Outstanding | 1013922344 | 70364060 | 1209909 | 29982557 | 1044 |
Income Statement Trend
Europlasma Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 1.7M | 1.2M | 2.4M | 2.5M | 4.2M |
Short-term Investments | 4.0K | 4.0K | 10.0K | 10.0K | 10.0K |
Accounts Receivable | 8.7M | 2.5M | 3.2M | 934.0K | 1.3M |
Inventory | 17.8M | 7.9M | 6.6M | 3.0M | 816.0K |
Other Current Assets | - | - | -2.0K | -1.0K | -2.0K |
Total Current Assets | 38.7M | 14.6M | 17.0M | 13.4M | 12.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 53.2M | 50.5M | 70.7M | 64.3M | 56.3M |
Goodwill | 363.0K | 155.0K | 168.0K | 184.0K | 98.0K |
Intangible Assets | 199.0K | 155.0K | 168.0K | 168.0K | 82.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | -1.0K | -2.0K | 1.0K | 2.0K |
Total Non-Current Assets | 24.2M | 30.7M | 37.7M | 27.1M | 14.2M |
Total Assets | 62.9M | 45.3M | 54.7M | 40.4M | 26.3M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 11.2M | 6.5M | 3.9M | 3.0M | 2.2M |
Short-term Debt | 3.5M | 6.5M | 4.5M | 1.3M | 6.4M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 8.9M | 6.2M | 7.2M | 7.4M | 13.6M |
Total Current Liabilities | 50.3M | 31.1M | 27.4M | 21.6M | 32.5M |
Non-Current Liabilities | |||||
Long-term Debt | 10.2M | 6.2M | 3.5M | 2.9M | 1.3M |
Deferred Tax Liabilities | 1.7M | 3.6M | 4.8M | 1.9M | 0 |
Other Non-Current Liabilities | 5.1M | 5.8M | 8.3M | 8.4M | 7.1M |
Total Non-Current Liabilities | 23.8M | 18.9M | 21.4M | 14.3M | 10.3M |
Total Liabilities | 74.0M | 50.0M | 48.9M | 36.0M | 42.7M |
Equity | |||||
Common Stock | 52.6M | 3.0M | 4.1M | 140.6M | 20.9M |
Retained Earnings | -15.3M | -14.7M | -15.9M | -12.7M | -9.9M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | -11.1M | -4.8M | 5.8M | 4.5M | -16.5M |
Key Metrics | |||||
Total Debt | 13.7M | 12.7M | 8.0M | 4.2M | 7.7M |
Working Capital | -11.6M | -16.5M | -10.4M | -8.3M | -20.4M |
Balance Sheet Composition
Europlasma Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -15.9M | -14.7M | -15.8M | -12.7M | -10.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | 0 | 388.0K | 3.0K |
Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
Operating Cash Flow | -23.3M | -18.1M | -18.1M | -12.3M | -12.5M |
Investing Activities | |||||
Capital Expenditures | -1.5M | -1.7M | -2.9M | -5.4M | -4.8M |
Acquisitions | - | 0 | 332.0K | 771.0K | - |
Investment Purchases | - | 0 | 0 | -9.0K | 0 |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -1.5M | -1.7M | -2.6M | -3.9M | -4.7M |
Financing Activities | |||||
Share Repurchases | -8.0K | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 10.9M | 12.1M | 4.8M | 3.1M | 6.6M |
Debt Repayment | -1.7M | -2.0M | -1.3M | -807.0K | -7.1M |
Financing Cash Flow | 14.1M | 10.1M | 14.6M | 22.2M | 19.5M |
Free Cash Flow | -12.4M | -11.7M | -8.0M | -23.6M | -16.9M |
Net Change in Cash | -10.7M | -9.7M | -6.1M | 6.1M | 2.3M |
Cash Flow Trend
Europlasma Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-0.21
Price to Sales
0.13
Profitability Ratios
Profit Margin
-35.71%
Operating Margin
-56.40%
Return on Equity
137.19%
Return on Assets
-30.38%
Financial Health
Current Ratio
0.77
Debt to Equity
-1.23
Beta
1.51
Per Share Data
EPS (TTM)
€-0.02
Book Value per Share
€-0.20
Revenue per Share
€211.14
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
aleup | 5.4M | -0.21 | - | 137.19% | -35.71% | -1.23 |
Veolia Environnement | 21.9B | 19.82 | 3.31 | 11.64% | 2.48% | 236.50 |
Derichebourg S.A | 993.5M | 13.15 | 0.92 | 10.46% | 2.98% | 82.59 |
Aurea | 58.0M | 56.36 | 0.79 | 1.45% | 0.43% | 72.06 |
Orège S.A | 16.8M | -1.79 | - | 17.12% | -279.70% | -1.43 |
Finaxo Environnement | 9.0M | 23.89 | - | -40.50% | 28.14% | - |
Financial data is updated regularly. All figures are in the company's reporting currency.